Oscar Health, Inc. (OSCR)
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: What You Should Know
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $30.61, denoting a -1.48% move from the preceding trading day.
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $31.2, indicating a +1.27% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: What You Should Know
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $31.44, representing a -2.3% change from its previous close.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR) closed at $28.52 in the latest trading session, marking a -3.16% move from the prior day.
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
Oscar Health, Inc. (OSCR) concluded the recent trading session at $29.16, signifying a -2.57% move from its prior day's close.
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $28.26, representing a -2.25% change from its previous close.
Oscar Health, Inc. (OSCR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Oscar Health, Inc. (OSCR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average
From a technical perspective, Oscar Health, Inc. (OSCR) is looking like an interesting pick, as it just reached a key level of support. OSCR recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
After Golden Cross, Oscar Health, Inc. (OSCR)'s Technical Outlook is Bright
Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript
Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For
Oscar Health (OSCR) delivered a standout Q1 2026, with $4.65B revenue, 52.7% YoY growth, and a 70.5% medical loss ratio. I reaffirm my Strong Buy rating and raise the 2026 price target to $30, citing robust execution and guidance reaffirmation. OSCR's SG&A leverage and technology platform drove operating efficiency, with Q1 Adjusted EBITDA at $727.1M and SG&A ratio likely below 15.8%.
Oscar Health, Inc. (OSCR) Beats Q1 Earnings Estimates
Oscar Health, Inc. (OSCR) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $0.92 per share a year ago.
